Quantcast

Latest Brain tumor Stories

2014-07-08 08:32:31

("Leading Edge" Gamma Knife Treatment, led by Christopher Duma, M.D., FACS and his team of researchers, offers hope to patients with Glioblastoma Multiforme) NEWPORT BEACH, Calif., July 8, 2014 /PRNewswire/ -- A study on the effects of an aggressive and strategic treatment called "Leading Edge" radiosurgery offers hope to patients diagnosed with life-threatening brain cancer. The study identifies the pathways of invasion of malignant glioma cells and provides a map in which a...

2014-07-07 10:11:17

McGill University Scientists at the Montreal Neurological Institute and Hospital, McGill University and McGill University Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma. The SUMO family proteins modify other proteins and the SUMOylation of proteins are critical for many cellular processes. Identifying SUMO’s role in the cancer cell...

2014-07-02 23:07:55

Facial paralysis expert Dr. Babak Azizzadeh, director of the Facial Paralysis Institute, announces his new position on the medical advisory board for the Acoustic Neuroma Association, a long-standing non-profit organization. Beverly Hills, CA (PRWEB) July 02, 2014 Dr. Babak Azizzadeh has strengthened his commitment to helping those affected by facial paralysis by joining the medical advisory board for the Acoustic Neuroma Association. The non-profit organization is dedicated to providing...

2014-07-02 16:24:28

In this phase two study, 50 percent of glioblastoma patients lived for two years, an encouraging result for one of the most deadly cancers that often kills patients within one year of diagnosis CHICAGO, July 2, 2014 /PRNewswire-USNewswire/ -- Patients newly diagnosed with glioblastoma multiforme (GBM) and treated with an experimental cancer vaccine made from the patient's own tumor in addition to standard of care lived longer compared to those who received standard of care alone,...

2014-07-01 23:05:50

American Brain Tumor Association’s Annual Conference puts a spotlight on integrated care. Chicago, IL (PRWEB) July 01, 2014 Integrative medicine — a combination of both alternative medicine and conventional treatments — may improve quality of life for brain tumor patients. At the American Brain Tumor Association’s annual patient and family conference July 25-26 in Chicago, experts will discuss the use of integrative medicine and how patients and caregivers can talk with their...

2014-06-30 23:05:29

Dr. Yaron Moshel and ANS Discuss How to Recognize the Symptoms of Pituitary Tumors Morristown, NJ (PRWEB) June 30, 2014 Did you know pituitary tumors affect 15-20% of adults, and are caused by an abnormal growth of cells? How would you know you are suffering from one? Joe Lagitch, 71, of Parsippany has never been sick. His wife, Betty, a retired nurse, says she was surprised when her husband started to complain of headaches, but shrugged it off as a simple sinus infection. Two days later,...

2014-06-30 23:04:20

American Brain Tumor Association and American Association of Neuroscience Nurses releases pediatric nursing clinical guidelines for brain tumor patients. Chicago, IL (PRWEB) June 30, 2014 To meet the unique needs of pediatric brain tumor patients, the American Brain Tumor Association (ABTA) and the American Association of Neuroscience Nurses (AANN) created a clinical practice guideline (CPG) that specializes in the treatment of children with brain tumors. An estimated 4,300 children will...

2014-06-30 08:30:17

SAN ANTONIO, June 30, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, releases the 2014 BIO International presentation by Chairman and CEO, Craig Dionne, PhD from the 2014 BIO International Convention held June 24th in San Diego, California. Dr. Dionne presented interim results from the Phase Ib and ongoing Phase II study for lead drug candidate, G-202. Summary: -- G-202 Data in Hepatocellular (HCC) Patients...

2014-06-27 14:56:01

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) A clinical phase I trial to examine the safety of the vaccine against gliomas based on mutant IDH1 in human patients is planned Astrocytomas and oligodendrogliomas are subtypes of a brain cancer called 'glioma'. These incurable brain tumors arise from glial cells, a type of support cell found in the central nervous system. "Low-grade gliomas", which grow comparatively slowly, spread in a diffuse manner across the...

2014-06-27 12:26:56

HOUSTON, June 27, 2014 /PRNewswire/ -- The Burzynski Research Institute, Inc. (BRI) announced today that it will present data on two of the Company's clinical-stage product candidates, Antineoplaston A10 injections (Atengenal(®)) and Antineoplaston AS2-1 injections (Astugenal(®)), at the 16(th) International Symposium on Pediatric Neuro-Oncology held in Singapore from June 28, 2014 to July 2, 2014. Abstracts and presentations are now available to the public in an online supplement...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related